Neurogene NGNE
NASDAQ NGNE
$25.65 -0.90 (-3.39%)
At close: Oct 2, 2026 · 4:00 PM EDT

Neurogene (NGNE) Return on Assets [ROA] (2014 - 2026)

Updated

Neurogene (NGNE) reported Return on Assets [ROA] of -43.99% for Q2 2026, down 16.09 percentage points from -27.90% a year earlier and down 7.69 percentage points from the prior quarter.

Analysis

Neurogene (NGNE) Return on Assets [ROA] (2014 - 2026) Analysis & Trends

For FY2025, Neurogene posted Return on Assets [ROA] of -29.40%, down 2.84 percentage points from FY2024.

  • Return on Assets [ROA] has a five-year change of -10.54 percentage points (FY2020 to FY2025).
  • By year, Return on Assets [ROA] came in at -26.56% in FY2024 (+5.17 pp), -31.73% in FY2023 (+8.77 pp), -40.50% in FY2022 (-8.02 pp) and -32.48% in FY2021 (-13.61 pp).
  • The Q2 2026 figure ranks as the lowest quarterly Return on Assets [ROA] since Q3 2023.
  • Year over year, Return on Assets [ROA] has now declined in each of the last three quarters, with an average year-over-year change of +0.98 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q1 2024 (a gain of 24.22 percentage points); the low point was Q4 2021 (a drop of 20.38 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -36.31% (Q1 2026), -31.85% (Q4 2025) and -29.45% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Neurogene 578.46 Mn 578.46 Mn - -43.99%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -43.99%
Mar 31, 2026 -36.31%
Dec 31, 2025 -31.85%
Sep 30, 2025 -29.45%
Jun 30, 2025 -27.90%
Mar 31, 2025 -24.70%
Dec 31, 2024 -29.67%
Sep 30, 2024 -40.04%
Jun 30, 2024 -33.63%
Mar 31, 2024 -27.20%
Dec 31, 2023 -33.73%
Sep 30, 2023 -54.86%
Jun 30, 2023 -51.33%
Mar 31, 2023 -51.42%
Dec 31, 2022 -47.93%
Sep 30, 2022 -45.54%
Jun 30, 2022 -43.24%
Mar 31, 2022 -39.13%
Dec 31, 2021 -35.79%
Sep 30, 2021 -32.05%
API Access

Neurogene Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NGNE&period=max&api_key=YOUR_API_KEY